MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Sonoma Pharmaceuticals P/CF Ratio 2011-2026 | SNOA
Annual P/CF Ratio Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41.6 | -0.0342 | -0.64 | -0.000724 | -2.36 | -1.56 | -0.619 | -1.36 | -3.38 | -1.79 | -1.09 | -3.81 | 29.3 | -6.46 | -11.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.3 | -41.6 | -3.1 |
P/CF Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-7.12 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-0.694 | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
-0.857 | $ 1.19 | 0.85 % | $ 128 M |  Canada |
 |
Aerie Pharmaceuticals
AERI
|
-3.28 | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-1.75 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
-20.4 | $ 2.67 | -0.74 % | $ 1.42 B | Canada |
 |
Agile Therapeutics
AGRX
|
-0.135 | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
40.5 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-0.923 | - | - | $ 50.1 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-2.09 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Eagle Pharmaceuticals
EGRX
|
6.7 | - | -39.89 % | $ 27.7 M | USA |
 |
HEXO Corp.
HEXO
|
-2.07 | - | 2.45 % | $ 38.1 M | Canada |
 |
Endo International plc
ENDP
|
0.157 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.449 | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
-0.673 | $ 13.9 | 5.7 % | $ 712 M | USA |
 |
OrganiGram Holdings
OGI
|
-13.3 | $ 1.68 | 0.6 % | $ 402 M | Canada |
 |
Pacira BioSciences
PCRX
|
6.22 | $ 26.0 | 2.73 % | $ 1.2 B | USA |
 |
Athenex
ATNX
|
-8.43 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-15.3 | $ 21.5 | - | $ 2.05 B |  France |
 |
Evolus
EOLS
|
-49.3 | $ 5.66 | -4.23 % | $ 351 M | USA |
 |
Harrow Health
HROW
|
90.5 | $ 51.0 | -4.67 % | $ 1.66 B | USA |
 |
China Pharma Holdings
CPHI
|
-9.74 | $ 1.35 | 5.88 % | $ 23.6 M |  China |
 |
Sundial Growers
SNDL
|
-0.00572 | $ 1.65 | -1.79 % | $ 3.37 M | Canada |
 |
Jupiter Wellness
JUPW
|
-1.95 | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
3.28 | $ 7.9 | 3.47 % | $ 2.88 B | Canada |
 |
Veru
VERU
|
-4.98 | $ 2.37 | 1.72 % | $ 320 M | USA |
 |
Lannett Company
LCI
|
0.647 | - | 1.15 % | $ 7.11 M | USA |
 |
cbdMD
YCBD
|
-4.77 | $ 1.1 | -4.35 % | $ 4.74 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-145 | $ 5.19 | 9.96 % | $ 73 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
-0.0334 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
29.2 | $ 4.3 | -1.38 % | $ 566 M | USA |
 |
Aurora Cannabis
ACB
|
-4.34 | $ 4.24 | - | $ 86.3 M | Canada |
 |
PetIQ
PETQ
|
6.4 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
-133 | - | -4.76 % | $ 65.3 M | USA |
 |
Perrigo Company plc
PRGO
|
10.9 | $ 14.59 | -1.19 % | $ 2 B | USA |
 |
ProPhase Labs
PRPH
|
4.57 | - | - | $ 5.07 M | USA |
 |
Rockwell Medical
RMTI
|
-3.77 | $ 0.95 | 2.78 % | $ 22.2 M | USA |
 |
Radius Health
RDUS
|
-16.8 | - | - | $ 1.42 B | USA |
 |
Relmada Therapeutics
RLMD
|
-3.13 | $ 4.32 | 5.88 % | $ 130 M | USA |
 |
OptiNose
OPTN
|
-9.33 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
1.33 | $ 9.43 | -1.05 % | $ 670 M | USA |
 |
PLx Pharma
PLXP
|
-3.68 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-2.26 | $ 5.61 | 2.19 % | $ 229 M | USA |
 |
SCYNEXIS
SCYX
|
1.17 | $ 0.64 | -0.05 % | $ 30.6 M | USA |
 |
Tricida
TCDA
|
-2.56 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
151 | $ 8.99 | -2.92 % | $ 5.56 B | Canada |
 |
TherapeuticsMD
TXMD
|
-2.79 | $ 2.04 | - | $ 21.3 M | USA |
 |
Viatris
VTRS
|
4.54 | $ 12.46 | 0.48 % | $ 15.1 B | USA |
 |
Zomedica Corp.
ZOM
|
-8.59 | - | -0.21 % | $ 98 M | USA |